![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag Hyprocure ![]() Related Tags American Podiatric Medical Association
Ankle Surgery Bunions Dpm Extra-osseous Talotarsal Stabilization Fallen Arches Flat Feet Foot Implant Foot Pain Foot Surgeon Foot Surgery Giii Graham International Implant Institute Gramedica Heel Pain Hip Pain Hyperpronation Knee Pain Plantar Fasciitis Talotarsal Dislocation
| hyprocure Latest News+ XML/RSSBy Graham International Implant Institute® Revolutionary Type II Extra-Osseous TaloTarsal Stabilization device celebrates 8 years of helping patients throughout the world end their suffering from the effects TaloTarsal Displacement. By GraMedica® Top Chinese surgeon travels to observe the HyProCure® procedure firsthand from leading U.S. foot and ankle surgeons. By GraMedica® Global orthopedic medical device company, GraMedica®, supports podiatric students in their efforts to raise money to help the Yucatan Crippled Children’s Project. By GraMedica® After 12 year old aspiring singer underwent the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure, she now has “normal looking feet” with no pain. All Press ReleasesBy Graham International Implant Institute® Michael E. Graham, DPM, FACFAS, FAENS, lectured on innovations in foot and ankle surgery at the 33rd Annual International Congress of the Dominican Society of Orthopedics and Traumatology. By Graham International Implant Institute® Michael E. Graham, DPM, lectures on evidence based medicine at AENS conference. By Graham International Implant Institute® Live sand animation demonstrates heartfelt tale of finding a real solution to foot pain. By Graham International Implant Institute® Radiographic Outcomes in Adult Patients using Type II Extra-Osseous TaloTarsal Stabilization with HyProCure® Show Transverse and Sagittal Plane Normalization. By Graham International Implant Institute® Scientific study of Extra-Osseous TaloTarsal Stabilization devices validates key differences in HyProCure® that allow for better biomechanical functioning leading to improved success rates. By Graham International Implant Institute® Revolutionary Type II Extra-Osseous TaloTarsal Stabilization device celebrates 8 years of helping patients throughout the world end their suffering from the effects TaloTarsal Displacement. By Graham International Implant Institute® The Graham International Implant Institute® honors Dr. Jian Zhong Zhang with prestigious award. By Graham International Implant Institute® Specialists in attendance at China’s leading Foot and Ankle Symposium gained valuable education on the Extra-Osseous TaloTarsal Stabilization Procedure. By Graham International Implant Institute® In a recent journey throughout China, innovator of the life changing HyProCure® procedure took time to educate surgeons, meet with patients and share his skills. By Graham International Implant Institute Pioneer in TaloTarsal Stabilization Speaks on the Biomechanics of the Talotarsal Mechanism. By GraMedica® Celebrating 100 Years, The National was a great success with lectures on the latest advances in the podiatric field, one of a kind festivities and a sold out exhibit hall. By Graham International Implant Institute Philip Bresnahan, DPM, FACFAS, provides insight into literature and studies that show the benefits of extra-osseous talotarsal stabilization (EOTTS) with HyProCure®. By GraMedica® 25-year-old finds solution to her flat feet, hip pain and knee pain via the simple, minimally invasive HyProCure® procedure. By GraMedica® Global orthopedic medical device company marks their 9th year providing superior treatment options. By GraMedica® Extra-Osseous TaloTarsal Stabilization (EOTTS) Device gaining recognition across the globe with the latest addition of distribution in Italy. By GraMedica® Top Chinese surgeon travels to observe the HyProCure® procedure firsthand from leading U.S. foot and ankle surgeons. By GraMedica® Diminishing her dream of becoming a ballerina, Wanshop's flat feet caused chronic foot, hip and back pain for most of her life. By GraMedica® Global orthopedic medical device company, GraMedica®, supports podiatric students in their efforts to raise money to help the Yucatan Crippled Children’s Project. By GraMedica® Surgeon chooses the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure for teen soccer player wishing to get back in the game. By Graham International Implant Institute Creator of the Innovative HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) device takes time to educate and lecture future surgeons. By GraMedica® Surgeon chooses the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure as a solution to talotarsal displacement for his patients and for himself. By GraMedica® After 12 year old aspiring singer underwent the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure, she now has “normal looking feet” with no pain. By GraMedica® Surgeon believes in product and ease of performing Extra-Osseous TaloTarsal Stabilization (EOTTS) with HyProCure® enough to let his family member undergo the surgery. By GraMedica® Recent article published by the International Federation of Podiatrists uses evidenced based medicine to support claim regarding EOTTS with HyProCure® By GraMedica With acceptance in the Chinese Market, GraMedica® gets closer to achieving goal of providing a real solution to patients suffering from misaligned feet globally. By GraMedica® HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) device offered as a superior treatment option to patients in China following the first HyProCure® procedures performed in the country. By Graham International Implant Institute Graham International Implant Institute's Symposium Provides Foot and Ankle Surgeons Information on Cutting-Edge Techniques and Bettering their Practice By GraMedica® GraMedica®, a global orthopedic medical device company, is proud to be a corporate sponsor of the American College of Foot and Ankle Pediatrics and to support their mission of education on the importance of caring for children’s feet. By GraMedica® Podiatric Success’s, Bret Ribotsky, DPM recently hosted Dr. Michael E. Graham, pioneer in Extra-Osseous TaloTarsal Stabilization and the inventor of HyProCure® on Meet the Masters. By GraMedica® Prestigious German Orthopedic Surgeon Recognizes GraMedica®’s Innovative Sinus Tarsi Implant as the Best Solution for the Correction of Flexible Flat Feet. By GraMedica® Evidence-based Analysis Proves Minimally Invasive Foot Implant by GraMedica® Offers Innovative Treatment Option with Significantly better Patient Outcomes than Similar Devices. By GraMedica® Top Chinese Foot Surgeon Invites HyProCure to His Clinic After Meeting the Creator of the Innovative Internal Extra-Osseous TaloTarsal Stabilization Device. By Graham International Implant Institute Surgeon with practice in Scottsdale, AZ, recognized for meeting the standards set by The Graham International Implant Institute in the use of the HyProCure® Internal, Extra-Osseous, Extra-Articular, TaloTarsal Fixation Device. By GraMedica® Surgeon from Bellmore, NY with vast experience using GraMedica®’s innovative sinus tarsi implant travels to Ecuador to educate and demonstrate the surgical procedure. By GraMedica Largest Association of Chinese Orthopedists Selects Dr. Michael E. Graham and HyProCure® Research for Inclusion in Conference Agenda. By GraMedica Six years later, minimally invasive implant continues to reverse common, yet devastating, foot condition and restore patients’ quality of life. Many people have talotarsal dislocation syndrome and suffer for years before finding out how to fix it. Page:
| ||||||||||||||||||||||